Labiana Health (XMAD:LAB) EV-to-Revenue : 0.91 (As of Jun. 05, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Labiana Health EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Labiana Health's enterprise value is €52.70 Mil. Labiana Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2022 was €57.85 Mil. Therefore, Labiana Health's EV-to-Revenue for today is 0.91.

The historical rank and industry rank for Labiana Health's EV-to-Revenue or its related term are showing as below:

XMAD:LAB's EV-to-Revenue is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.26
* Ranked among companies with meaningful EV-to-Revenue only.

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-05), Labiana Health's stock price is €2.36. Labiana Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2022 was €8.01. Therefore, Labiana Health's PS Ratio for today is 0.29.

Labiana Health EV-to-Revenue Historical Data

The historical data trend for Labiana Health's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health EV-to-Revenue Chart

Labiana Health Annual Data

Trend

Dec20

Dec21

Dec22

EV-to-Revenue

1.03

Labiana Health Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22
EV-to-Revenue	-	-	-	1.03

Competitive Comparison of Labiana Health's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labiana Health's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Labiana Health's EV-to-Revenue falls into.

Labiana Health EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Labiana Health's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	52.695	/	57.848
	=	0.91

Labiana Health's current Enterprise Value is €52.70 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Labiana Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2022 was €57.85 Mil.

Labiana Health (XMAD:LAB) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Labiana Health's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	2.36	/	8.012
	=	0.29

Labiana Health's share price for today is €2.36.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2022 was €8.01.

Labiana Health EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Labiana Health's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Labiana Health (XMAD:LAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » EV-to-Revenue

Traded in Other Exchanges

N/A

Address

Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023

Website

https://www.labiana.com

Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.